| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |